H1043 - 2020 COVID-19 Recovery Act. (SL 2020-4)

Overview: Section 3.3(22) of S.L. 2020-4, requires the Office of State Budget and Management to allocate $15 million of the funds appropriated from the Coronavirus Relief Fund to the Duke University Human Vaccine Institute (DHVI) of the Duke University School of Medicine to develop a safe and effective COVID-19 vaccine. This initial allocation became effective May 4, 2020.

Section 1.2 of S.L. 2020-97 amended Section 3.3(22) of S.L. 2020-4, to increase the allocation from $15 million to $17 million and to require the DHVI to develop both (i) a safe and effective COVID-19 vaccine and (ii) rapid, low-cost COVID-19 testing for active infections. This additional allocation and requirement became effective September 4, 2020.